カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

関節リウマチ治療薬の世界市場2022：医薬品、バイオ医薬品

■ 英語タイトル：Global Rhematoid Arthritis Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3917）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3917
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[関節リウマチ治療薬の世界市場2022：医薬品、バイオ医薬品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の関節リウマチ治療薬市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の関節リウマチ治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

関節リウマチ治療薬市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・医薬品、バイオ医薬品

アプリケーション別セグメントは次のように区分されます。
・処方箋、OTC

世界の関節リウマチ治療薬市場の主要な市場プレーヤーは以下のとおりです。
・AbbVie Inc、Hoffman-La Roche AG、Amgen Inc、Pfizer Inc、Bristol-Myers Squibb Co、Johnson & Johnson、UCB Biosciences Inc、Mitsubishi Tanabe Pharma Corp、Biogen Inc、Merck & Co

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、関節リウマチ治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な関節リウマチ治療薬メーカーの企業概要、2019年～2022年までの関節リウマチ治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な関節リウマチ治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別関節リウマチ治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの関節リウマチ治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での関節リウマチ治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および関節リウマチ治療薬の産業チェーンを掲載しています。
・第13、14、15章では、関節リウマチ治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 関節リウマチ治療薬の概要
– 種類別分析（2017年vs2021年vs2028年）：医薬品、バイオ医薬品
– 用途別分析（2017年vs2021年vs2028年）：処方箋、OTC
– 世界の関節リウマチ治療薬市場規模・予測
– 世界の関節リウマチ治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AbbVie Inc、Hoffman-La Roche AG、Amgen Inc、Pfizer Inc、Bristol-Myers Squibb Co、Johnson & Johnson、UCB Biosciences Inc、Mitsubishi Tanabe Pharma Corp、Biogen Inc、Merck & Co
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：医薬品、バイオ医薬品
・用途別分析2017年-2028年：処方箋、OTC
・関節リウマチ治療薬の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・関節リウマチ治療薬のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・関節リウマチ治療薬のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・関節リウマチ治療薬の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・関節リウマチ治療薬の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Rhematoid Arthritis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rhematoid Arthritis Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Pharmaceuticals
1.2.3 Biopharmaceuticals
1.3 Market Analysis by Application
1.3.1 Overview: Global Rhematoid Arthritis Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Prescription
1.3.3 OTC
1.4 Global Rhematoid Arthritis Drugs Market Size & Forecast
1.4.1 Global Rhematoid Arthritis Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Rhematoid Arthritis Drugs Sales in Volume (2017-2028)
1.4.3 Global Rhematoid Arthritis Drugs Price (2017-2028)
1.5 Global Rhematoid Arthritis Drugs Production Capacity Analysis
1.5.1 Global Rhematoid Arthritis Drugs Total Production Capacity (2017-2028)
1.5.2 Global Rhematoid Arthritis Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rhematoid Arthritis Drugs Market Drivers
1.6.2 Rhematoid Arthritis Drugs Market Restraints
1.6.3 Rhematoid Arthritis Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business
2.1.3 AbbVie Inc Rhematoid Arthritis Drugs Product and Services
2.1.4 AbbVie Inc Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hoffman-La Roche AG
2.2.1 Hoffman-La Roche AG Details
2.2.2 Hoffman-La Roche AG Major Business
2.2.3 Hoffman-La Roche AG Rhematoid Arthritis Drugs Product and Services
2.2.4 Hoffman-La Roche AG Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Amgen Inc
2.3.1 Amgen Inc Details
2.3.2 Amgen Inc Major Business
2.3.3 Amgen Inc Rhematoid Arthritis Drugs Product and Services
2.3.4 Amgen Inc Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer Inc
2.4.1 Pfizer Inc Details
2.4.2 Pfizer Inc Major Business
2.4.3 Pfizer Inc Rhematoid Arthritis Drugs Product and Services
2.4.4 Pfizer Inc Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bristol-Myers Squibb Co
2.5.1 Bristol-Myers Squibb Co Details
2.5.2 Bristol-Myers Squibb Co Major Business
2.5.3 Bristol-Myers Squibb Co Rhematoid Arthritis Drugs Product and Services
2.5.4 Bristol-Myers Squibb Co Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Rhematoid Arthritis Drugs Product and Services
2.6.4 Johnson & Johnson Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 UCB Biosciences Inc
2.7.1 UCB Biosciences Inc Details
2.7.2 UCB Biosciences Inc Major Business
2.7.3 UCB Biosciences Inc Rhematoid Arthritis Drugs Product and Services
2.7.4 UCB Biosciences Inc Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mitsubishi Tanabe Pharma Corp
2.8.1 Mitsubishi Tanabe Pharma Corp Details
2.8.2 Mitsubishi Tanabe Pharma Corp Major Business
2.8.3 Mitsubishi Tanabe Pharma Corp Rhematoid Arthritis Drugs Product and Services
2.8.4 Mitsubishi Tanabe Pharma Corp Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biogen Inc
2.9.1 Biogen Inc Details
2.9.2 Biogen Inc Major Business
2.9.3 Biogen Inc Rhematoid Arthritis Drugs Product and Services
2.9.4 Biogen Inc Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Merck & Co
2.10.1 Merck & Co Details
2.10.2 Merck & Co Major Business
2.10.3 Merck & Co Rhematoid Arthritis Drugs Product and Services
2.10.4 Merck & Co Rhematoid Arthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Rhematoid Arthritis Drugs Breakdown Data by Manufacturer
3.1 Global Rhematoid Arthritis Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Rhematoid Arthritis Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Rhematoid Arthritis Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Rhematoid Arthritis Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Rhematoid Arthritis Drugs Manufacturer Market Share in 2021
3.5 Global Rhematoid Arthritis Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Rhematoid Arthritis Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rhematoid Arthritis Drugs Market Size by Region
4.1.1 Global Rhematoid Arthritis Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Rhematoid Arthritis Drugs Revenue by Region (2017-2028)
4.2 North America Rhematoid Arthritis Drugs Revenue (2017-2028)
4.3 Europe Rhematoid Arthritis Drugs Revenue (2017-2028)
4.4 Asia-Pacific Rhematoid Arthritis Drugs Revenue (2017-2028)
4.5 South America Rhematoid Arthritis Drugs Revenue (2017-2028)
4.6 Middle East and Africa Rhematoid Arthritis Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Rhematoid Arthritis Drugs Sales in Volume by Type (2017-2028)
5.2 Global Rhematoid Arthritis Drugs Revenue by Type (2017-2028)
5.3 Global Rhematoid Arthritis Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Rhematoid Arthritis Drugs Sales in Volume by Application (2017-2028)
6.2 Global Rhematoid Arthritis Drugs Revenue by Application (2017-2028)
6.3 Global Rhematoid Arthritis Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Rhematoid Arthritis Drugs Sales by Type (2017-2028)
7.2 North America Rhematoid Arthritis Drugs Sales by Application (2017-2028)
7.3 North America Rhematoid Arthritis Drugs Market Size by Country
7.3.1 North America Rhematoid Arthritis Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Rhematoid Arthritis Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Rhematoid Arthritis Drugs Sales by Type (2017-2028)
8.2 Europe Rhematoid Arthritis Drugs Sales by Application (2017-2028)
8.3 Europe Rhematoid Arthritis Drugs Market Size by Country
8.3.1 Europe Rhematoid Arthritis Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Rhematoid Arthritis Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Rhematoid Arthritis Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Rhematoid Arthritis Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Rhematoid Arthritis Drugs Market Size by Region
9.3.1 Asia-Pacific Rhematoid Arthritis Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Rhematoid Arthritis Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Rhematoid Arthritis Drugs Sales by Type (2017-2028)
10.2 South America Rhematoid Arthritis Drugs Sales by Application (2017-2028)
10.3 South America Rhematoid Arthritis Drugs Market Size by Country
10.3.1 South America Rhematoid Arthritis Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Rhematoid Arthritis Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rhematoid Arthritis Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Rhematoid Arthritis Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Rhematoid Arthritis Drugs Market Size by Country
11.3.1 Middle East & Africa Rhematoid Arthritis Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Rhematoid Arthritis Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Rhematoid Arthritis Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Rhematoid Arthritis Drugs
12.3 Rhematoid Arthritis Drugs Production Process
12.4 Rhematoid Arthritis Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Rhematoid Arthritis Drugs Typical Distributors
13.3 Rhematoid Arthritis Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Rhematoid Arthritis Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Rhematoid Arthritis Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Inc Major Business
Table 5. AbbVie Inc Rhematoid Arthritis Drugs Product and Services
Table 6. AbbVie Inc Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Hoffman-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 8. Hoffman-La Roche AG Major Business
Table 9. Hoffman-La Roche AG Rhematoid Arthritis Drugs Product and Services
Table 10. Hoffman-La Roche AG Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 12. Amgen Inc Major Business
Table 13. Amgen Inc Rhematoid Arthritis Drugs Product and Services
Table 14. Amgen Inc Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Inc Major Business
Table 17. Pfizer Inc Rhematoid Arthritis Drugs Product and Services
Table 18. Pfizer Inc Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Co Major Business
Table 21. Bristol-Myers Squibb Co Rhematoid Arthritis Drugs Product and Services
Table 22. Bristol-Myers Squibb Co Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Rhematoid Arthritis Drugs Product and Services
Table 26. Johnson & Johnson Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. UCB Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 28. UCB Biosciences Inc Major Business
Table 29. UCB Biosciences Inc Rhematoid Arthritis Drugs Product and Services
Table 30. UCB Biosciences Inc Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mitsubishi Tanabe Pharma Corp Basic Information, Manufacturing Base and Competitors
Table 32. Mitsubishi Tanabe Pharma Corp Major Business
Table 33. Mitsubishi Tanabe Pharma Corp Rhematoid Arthritis Drugs Product and Services
Table 34. Mitsubishi Tanabe Pharma Corp Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Biogen Inc Basic Information, Manufacturing Base and Competitors
Table 36. Biogen Inc Major Business
Table 37. Biogen Inc Rhematoid Arthritis Drugs Product and Services
Table 38. Biogen Inc Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 40. Merck & Co Major Business
Table 41. Merck & Co Rhematoid Arthritis Drugs Product and Services
Table 42. Merck & Co Rhematoid Arthritis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Rhematoid Arthritis Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Rhematoid Arthritis Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Rhematoid Arthritis Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Rhematoid Arthritis Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Rhematoid Arthritis Drugs Production Site of Key Manufacturer
Table 48. Rhematoid Arthritis Drugs New Entrant and Capacity Expansion Plans
Table 49. Rhematoid Arthritis Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Rhematoid Arthritis Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Global Rhematoid Arthritis Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Global Rhematoid Arthritis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Rhematoid Arthritis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Rhematoid Arthritis Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Global Rhematoid Arthritis Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Global Rhematoid Arthritis Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Rhematoid Arthritis Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Rhematoid Arthritis Drugs Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Rhematoid Arthritis Drugs Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Rhematoid Arthritis Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Global Rhematoid Arthritis Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Global Rhematoid Arthritis Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Rhematoid Arthritis Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Rhematoid Arthritis Drugs Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Rhematoid Arthritis Drugs Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Rhematoid Arthritis Drugs Sales by Country (2017-2022) & (K Units)
Table 67. North America Rhematoid Arthritis Drugs Sales by Country (2023-2028) & (K Units)
Table 68. North America Rhematoid Arthritis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Rhematoid Arthritis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Rhematoid Arthritis Drugs Sales by Type (2017-2022) & (K Units)
Table 71. North America Rhematoid Arthritis Drugs Sales by Type (2023-2028) & (K Units)
Table 72. North America Rhematoid Arthritis Drugs Sales by Application (2017-2022) & (K Units)
Table 73. North America Rhematoid Arthritis Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Europe Rhematoid Arthritis Drugs Sales by Country (2017-2022) & (K Units)
Table 75. Europe Rhematoid Arthritis Drugs Sales by Country (2023-2028) & (K Units)
Table 76. Europe Rhematoid Arthritis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Rhematoid Arthritis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Rhematoid Arthritis Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Europe Rhematoid Arthritis Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Europe Rhematoid Arthritis Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Europe Rhematoid Arthritis Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Rhematoid Arthritis Drugs Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Rhematoid Arthritis Drugs Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Rhematoid Arthritis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Rhematoid Arthritis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Rhematoid Arthritis Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Rhematoid Arthritis Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Rhematoid Arthritis Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Rhematoid Arthritis Drugs Sales by Application (2023-2028) & (K Units)
Table 90. South America Rhematoid Arthritis Drugs Sales by Country (2017-2022) & (K Units)
Table 91. South America Rhematoid Arthritis Drugs Sales by Country (2023-2028) & (K Units)
Table 92. South America Rhematoid Arthritis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Rhematoid Arthritis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Rhematoid Arthritis Drugs Sales by Type (2017-2022) & (K Units)
Table 95. South America Rhematoid Arthritis Drugs Sales by Type (2023-2028) & (K Units)
Table 96. South America Rhematoid Arthritis Drugs Sales by Application (2017-2022) & (K Units)
Table 97. South America Rhematoid Arthritis Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Rhematoid Arthritis Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Rhematoid Arthritis Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Rhematoid Arthritis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Rhematoid Arthritis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Rhematoid Arthritis Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Rhematoid Arthritis Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Rhematoid Arthritis Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Rhematoid Arthritis Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Rhematoid Arthritis Drugs Raw Material
Table 107. Key Manufacturers of Rhematoid Arthritis Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Rhematoid Arthritis Drugs Typical Distributors
Table 111. Rhematoid Arthritis Drugs Typical Customers
List of Figures
Figure 1. Rhematoid Arthritis Drugs Picture
Figure 2. Global Rhematoid Arthritis Drugs Revenue Market Share by Type in 2021
Figure 3. Pharmaceuticals
Figure 4. Biopharmaceuticals
Figure 5. Global Rhematoid Arthritis Drugs Revenue Market Share by Application in 2021
Figure 6. Prescription
Figure 7. OTC
Figure 8. Global Rhematoid Arthritis Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Rhematoid Arthritis Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Rhematoid Arthritis Drugs Sales (2017-2028) & (K Units)
Figure 11. Global Rhematoid Arthritis Drugs Price (2017-2028) & (USD/Unit)
Figure 12. Global Rhematoid Arthritis Drugs Production Capacity (2017-2028) & (K Units)
Figure 13. Global Rhematoid Arthritis Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Rhematoid Arthritis Drugs Market Drivers
Figure 15. Rhematoid Arthritis Drugs Market Restraints
Figure 16. Rhematoid Arthritis Drugs Market Trends
Figure 17. Global Rhematoid Arthritis Drugs Sales Market Share by Manufacturer in 2021
Figure 18. Global Rhematoid Arthritis Drugs Revenue Market Share by Manufacturer in 2021
Figure 19. Rhematoid Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Rhematoid Arthritis Drugs Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Rhematoid Arthritis Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Rhematoid Arthritis Drugs Sales Market Share by Region (2017-2028)
Figure 23. Global Rhematoid Arthritis Drugs Revenue Market Share by Region (2017-2028)
Figure 24. North America Rhematoid Arthritis Drugs Revenue (2017-2028) & (USD Million)
Figure 25. Europe Rhematoid Arthritis Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Rhematoid Arthritis Drugs Revenue (2017-2028) & (USD Million)
Figure 27. South America Rhematoid Arthritis Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Rhematoid Arthritis Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Global Rhematoid Arthritis Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Rhematoid Arthritis Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Rhematoid Arthritis Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Rhematoid Arthritis Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Rhematoid Arthritis Drugs Revenue Market Share by Application (2017-2028)
Figure 34. Global Rhematoid Arthritis Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Rhematoid Arthritis Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Rhematoid Arthritis Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Rhematoid Arthritis Drugs Sales Market Share by Country (2017-2028)
Figure 38. North America Rhematoid Arthritis Drugs Revenue Market Share by Country (2017-2028)
Figure 39. United States Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Rhematoid Arthritis Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Rhematoid Arthritis Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Rhematoid Arthritis Drugs Sales Market Share by Country (2017-2028)
Figure 45. Europe Rhematoid Arthritis Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Germany Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Rhematoid Arthritis Drugs Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Rhematoid Arthritis Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Rhematoid Arthritis Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Rhematoid Arthritis Drugs Revenue Market Share by Region (2017-2028)
Figure 55. China Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Rhematoid Arthritis Drugs Sales Market Share by Type (2017-2028)
Figure 62. South America Rhematoid Arthritis Drugs Sales Market Share by Application (2017-2028)
Figure 63. South America Rhematoid Arthritis Drugs Sales Market Share by Country (2017-2028)
Figure 64. South America Rhematoid Arthritis Drugs Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Rhematoid Arthritis Drugs Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Rhematoid Arthritis Drugs Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Rhematoid Arthritis Drugs Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Rhematoid Arthritis Drugs Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Rhematoid Arthritis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Rhematoid Arthritis Drugs in 2021
Figure 76. Manufacturing Process Analysis of Rhematoid Arthritis Drugs
Figure 77. Rhematoid Arthritis Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ブランド医薬品の世界市場2022：バイオ医薬品、ケミカル医薬品
  • 世界の熱傷治療市場2023～2027：高度熱傷治療、バイオ医薬品、従来型熱傷治療
  • 世界のプロテオミクス市場（〜2028年）：製品別（分光法、クロマトグラフィー、電気泳動、X線結晶構造解析）、試薬別、サービス別（コアプロテオミクス、バイオインフォマティクス）、用途別（診断、創薬）、エンドユーザー別（病院、研究室、バイオ医薬品）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3917 )"関節リウマチ治療薬の世界市場2022：医薬品、バイオ医薬品" (英文：Global Rhematoid Arthritis Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。